Nomura Holdings’s ChemoCentryx, Inc. CCXI Stock Holding History

Nomura Holdings’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-47,000	Closed	-$631K	–	2325
2021 Q2	$631K	Buy	+47,000	New	+$1.16M	﹤0.01%	1238
2021 Q1	–	Sell	-4,300	Closed	-$266K	–	2378
2020 Q4	$266K	Buy	+4,300	New	+$246K	﹤0.01%	1347
2016 Q2	–	Sell	-17,000	Closed	-$42K	–	1718
2016 Q1	$42K	Buy	+17,000	New	+$61.9K	﹤0.01%	1460

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Nomura Holdings's CCXI Position: Q3 2021 in Review

Nomura Holdings sold out of ChemoCentryx, Inc. (CCXI) in Q3 2021, closing a stake of 47,000 shares — an estimated $631K sold.

Nomura Holdings first reported a position in CCXI in Q1 2016 and held it in 3 quarters. The position peaked at $631K in Q2 2021. 140 funds tracked by Wall St. Rank hold CCXI as of Q3 2021.

Nomura Holdings reported no remaining ChemoCentryx, Inc. position as of Q3 2021 after selling out during the quarter.
Nomura Holdings sold 47,000 ChemoCentryx, Inc. shares in Q3 2021, an estimated $631K.
Nomura Holdings first reported a position in ChemoCentryx, Inc. in Q1 2016 and held it in 3 quarters.
Nomura Holdings's ChemoCentryx, Inc. position peaked at $631K in Q2 2021.
140 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2021.

Based on Nomura Holdings's 13F filing for Q3 2021, filed 15 Nov 2021.